Eloralintide
ENLIGHTEN-2
Eli Lilly · Phase 3 · Recruiting · Enrollment 1035
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Eloralintide Dose 1 | n/r | n/r | n/r | n/r | n/r |
| Eloralintide Dose 2 | n/r | n/r | n/r | n/r | n/r |
| Eloralintide Dose 3 | n/r | n/r | n/r | n/r | n/r |
| Eloralintide Dose 4 | n/r | n/r | n/r | n/r | n/r |
| Placebo | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.